Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of BBIBP-CorV in Thai pregnant women
TCTR20210923013Phase 3Not yet recruiting
- Sponsor
- Chulabhorn Hospital
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Chulabhorn Hospital. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210923013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210923013.